Skip to content

LeMaitre Vascular LMAT Accrued Liabilities, Current

Accrued Liabilities, Current at other companies

Becton, Dickinson and Company logo
Becton, Dickinson and CompanyBDX
$3.1B-10.7%
ITG
Integer HoldingsITGR
Merit Medical Systems logo
Merit Medical SystemsMMSI
Baxter International logo
Baxter InternationalBAX
TFX
TeleflexTFX
Solventum logo
SolventumSOLV

Other financials

Income statement

See full
Revenue$66.6M+11.2%
Gross profit$48.4M+16.8%
Operating income$17.8M+40.8%
Net income$15.7M+42.4%
EPS (diluted)$0.68+41.7%

Balance sheet

See full
Cash & equivalents$26.9M+6.0%
Total debt$20.9M+20.6%
Total equity$406.6M+17.0%
Total assets$629.5M+13.2%

Cash flow

See full
Operating cash flow$15.1M+67.0%
CapEx$2.8M+101%
Free cash flow$12.3M+60.8%

Valuation

See full
Market cap$2.1B+31.4%
Enterprise value$2.1B+31.6%
P/E33.7×-1.7×
P/S8.2×+1.1×

Profitability

See full
Gross margin72.4%+3.6pp
Operating margin28.5%+5.1pp
Net margin24.3%+4.4pp
FCF margin30.9%+12.7pp

Returns & leverage

See full
Return on equity16.5%+2.8pp
Debt / equity0.1×0.0×
Current ratio14.3×-2.2×

Where this comes from

Reported directly by LeMaitre Vascular in its filing.

Tagged under the XBRL concept us-gaap:AccruedLiabilitiesCurrent.

The official record: LeMaitre Vascular’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about LeMaitre Vascular's accrued liabilities, current.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is LeMaitre Vascular's accrued liabilities, current?
LeMaitre Vascular (LMAT) reported accrued liabilities, current of $25.27M in Q1 2026.
How has LeMaitre Vascular's accrued liabilities, current changed year-over-year?
LeMaitre Vascular's accrued liabilities, current increased by 26.8% year-over-year, from $19.93M to $25.27M.
What is the long-term trend for LeMaitre Vascular's accrued liabilities, current?
Over 5 years (2020 to 2025), LeMaitre Vascular's accrued liabilities, current has grown at a 10.9% compound annual growth rate (CAGR), from $17.53M to $29.41M.